The first-in-human study of the hydrogen sulfate (Hyd-sulfate) capsule of the MEK1/2 inhibitor AZD6244 (ARRY-142886): a phase I open-label multicenter trial in patients with advanced cancer (Q43152544)
Jump to navigation
Jump to search
scientific article published on 23 February 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The first-in-human study of the hydrogen sulfate (Hyd-sulfate) capsule of the MEK1/2 inhibitor AZD6244 (ARRY-142886): a phase I open-label multicenter trial in patients with advanced cancer |
scientific article published on 23 February 2010 |
Statements
1 reference
The first-in-human study of the hydrogen sulfate (Hyd-sulfate) capsule of the MEK1/2 inhibitor AZD6244 (ARRY-142886): a phase I open-label multicenter trial in patients with advanced cancer (English)
1 reference
1 reference
D Ross Camidge
1 reference
Henk M W Verheul
1 reference
Roshan Agarwal
1 reference
Debashis Sarker
1 reference
Stan B Kaye
1 reference
Ingrid M E Desar
1 reference
Johanna N H Timmer-Bonte
1 reference
S Gail Eckhardt
1 reference
Karl D Lewis
1 reference
Kathryn H Brown
1 reference
Mireille V Cantarini
1 reference
Clive Morris
1 reference
Sarah M A George
1 reference
Paul D Smith
1 reference
Carla M L van Herpen
1 reference
23 February 2010
1 reference
1 reference
Identifiers
1 reference